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Parkinson’s disease (PD) is characterized by motor symptoms with depression. We
evaluated the influence of dopaminergic depletion on hippocampal neurogenesis
process to explore mechanisms of depression production. Five consecutive days
of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) injection in mice (MPTP-mice)
reduced dopaminergic fibers in hippocampal dentate gyrus (DG). MPTP-mice exhibited
depressive-like behaviors later for 2–3 weeks. BrdU was injected 4 h after last-injection
of MPTP. BrdU-positive (BrdU+) cells in dorsal (d-DG) and ventral (v-DG) DG were
examined on day 1 (D1), 7 (D7), 14 (D14) and 21 (D21) after BrdU injection. Fewer
D7-, D14- and D21-BrdU+ cells or BrdU+/NeuN+ cells, but not D1-BrdU+ cells, were
found in v-DG of MPTP-mice than in controls. However, the number of BrdU+ cells in
d-DG did not differ between the both. Loss of doublecortin-positive (DCX+) cells was
observed in v-DG of MPTP-mice. Protein kinase A (PKA) and Ca2+/cAMP-response
element binding protein (CREB) phosphorylation were reduced in v-DG of MPTP-mice,
which were reversed by D1-like receptor (D1R) agonist SKF38393, but not D2R agonist
quinpirole. The treatment of MPTP-mice with SKF38393 on days 2–7 after BrdU-
injection reduced the loss of D7- and D21-BrdU+ cells in v-DG and improved the
depressive-like behaviors; these changes were sensitive to PKA inhibitor H89. Moreover,
the v-DG injection of SKF38393 in MPTP-mice could reduce the loss of D21-BrdU+
cells and relieve the depressive-like behaviors. In control mice, the blockade of D1R by
SCH23390 caused the reduction of D21-BrdU+ cells in v-DG and the depressive-like
behaviors. Our results indicate that MPTP-reduced dopaminergic depletion impairs the
D1R-mediated early survival of newborn neurons in v-DG, producing depressive-like
behaviors.
Keywords: Parkinson’s disease (PD), dopaminergic receptor (DR), depression, neurogenesis, hippocampal
dentate gyrus (DG)
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INTRODUCTION
Parkinson’s disease (PD) is a neurodegenerative disorder
characterized by motor symptoms and a progressive loss of
dopaminergic neurons (Rodriguez-Oroz et al., 2009). Major
depression is present in approximately 30–50% of PD patients
(Bower et al., 2010; Nègre-Pagès et al., 2010). However, the
underlying mechanisms remain unclear.
The hippocampal volume is smaller in patients with
depression than in normal subjects of the same-age (Videbech
and Ravnkilde, 2015). Electroconvulsive therapy in refractory
depression can increase hippocampal volume. Growing evidence
suggests that neurogenesis continues throughout adulthood
within the hippocampal dentate gyrus (DG; Toni et al., 2008).
The newly generated neurons can integrate into hippocampal
circuitry, thereby maintaining a functional structure, which
is required for mood control and antidepressant efficacy
(Petrik et al., 2012). The deficits in adult neurogenesis in
the postmortem brains of PD patients have recently attracted
much attention. For example, Höglinger et al. (2004) have
reported the deficits in the hippocampal neurogenesis of
PD patients. The hippocampal cell proliferation capacity is
decreased in PD patients (Guiard et al., 2009). A reduction in
neuronal precursor cells has been observed in the subgranular
zone (SGZ) of patients with PD (Borta and Höglinger,
2007).
The hippocampus and the midbrain dopaminergic neurons
of the ventral tegmental area (VTA) form a functional loop
(Lisman and Grace, 2005). Dopaminergic fibers, originating
mainly from VTA (Gasbarri et al., 1997), directly contact the
newborn cells in DG, but are sparse in the granule cell layer
or adjacent hilus (Höglinger et al., 2004). Neuronal precursor
cells in the hippocampal DG of adult mammals express all
dopaminergic receptors (DRs), which receive dopaminergic
afferents (Takamura et al., 2014). Dopamine (DA) has been
reported to play an important role in the regulation of
endogenous neurogenesis in the adult mammalian brain. The
activation of D1-like receptors (D1R) promotes the survival of
newborn cells in the adult hippocampus (Takamura et al., 2014).
Winner et al. (2009) have observed that a D2-like receptor
(D2R) agonist in DA-depleted rats increases the proliferation
of neural precursor cells in the subventricular zone (SVZ) but
not in SGZ. A large body of evidence has established that
the DA depletion in rodents decreases the cell proliferation
and survival of neuronal precursor cells in DG (Höglinger
et al., 2004; Khaindrava et al., 2011). However, other data have
revealed that the DA depletion increases or has no effect on
cell proliferation (Oizumi et al., 2008; Park and Enikolopov,
2010).
In rodents and primates, the changes in afferent and efferent
connectivity along the longitudinal axis of the hippocampus
suggest distinct functions of the dorsal and ventral hippocampus.
The dorsal DG (d-DG) receives projections arising in the
lateral and caudomedial portion of entorhinal cortex, whereas
the ventral DG (v-DG) receives inputs from the rostromedial
region of the entorhinal cortex (Dolorfo and Amaral, 1998).
The innervation density of dopaminergic plexuses is very
high in the ventral hippocampus, but is low in the dorsal
portion (Bjarkam et al., 2003). 1-Methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) is commonly used to prepare an
animal model of PD as it selectively induces cell death of
dopaminergic neurons (Schober, 2004). The MPTP lesion can
be used for behavioral studies of affective disorders in C57BL/6
mice (Gorton et al., 2010). To investigate whether the DA
depletion in PD brain impairs the hippocampal neurogenesis to
cause the depression, we in this study examined the affective
behaviors and the neurogenesis process of d-DG and v-DG
(including the proliferation of stem cells, the differentiation
of progenitor cells and the survival of newborn neurons)
in mice treated with MPTP (MPTP-mice), and explored the
correlation between hippocampal neurogenesis deficits and
depressive-like behaviors. The present study provides evidence
that MPTP-reduced dopaminergic afferents impairs the D1R-
mediated early survival of newly generated neurons in v-DG,
which may be responsible for the production of depressive-like
behaviors.
MATERIALS AND METHODS
Mice
The use of animals was approved by Institutional Animal
Care and Use Committee of Nanjing Medical University and
was performed in accordance with the experimental animal
guidelines of Laboratory Animal Research Institute. Eight-week-
old male C57BL/6 mice (24–26 g; Oriental Bio Service Inc.,
Nanjing, China) were used at the beginning of the experiment.
The mice were maintained under constant environmental
conditions (temperature 23 ± 2◦C, humidity 55 ± 5% and
12:12 h light/dark cycle) in Animal Research Center of Nanjing
Medical University with free access to food and water.
Drug Administration
The mice received an intraperitoneal (i.p.) injection of MPTP
(25 mg/kg, measured as free base; Sigma-Aldrich, St. Louis,
MO, USA) once a day for five consecutive days (Crocker
et al., 2003). BrdU (Sigma-Aldrich) was dissolved freshly in
0.9% saline to make 10 mg/ml solution just before injection.
Mice were given three injections of BrdU (50 mg/kg, i.p.)
at intervals of 6 h. SKF38393 (Tocris, UK), SCH23390 and
quinpirole (Sigma-Aldrich) were dissolved in sterile saline;
L-sulpiride and H89 (Sigma-Aldrich) were dissolved in 1.0%
DMSO (Sutton and Caron, 2015). The mice were treated daily
with the injection (i.p.) of SKF38393 (10 mg/kg), H89 (1 mg/kg;
Seyedi et al., 2014), quinpirole (2 mg/kg), SCH23390 (0.5 mg/kg)
or L-sulpiride (15 mg/kg). For the v-DG injection of drugs,
the mice were anesthetized with chloral hydrate (400 mg/kg,
i.p.) and placed in a stereotaxic instrument (Stoelting, Wood
Dale, IL, USA). The scalp was incised and a small hole
(2 mm diameter) was drilled in the skull using a dental drill.
Guide cannulas (26-Gauge, Plastics One, Roanoke, VA, USA)
were implanted into the bilateral v-DG (2.3 mm posterior,
1.3 mm lateral and 2.0 mm ventral to Bregma; Zhou et al.,
2011b). On day 2 after surgery, the dummy cannulas were
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removed from the guide cannula, and then replaced by infusion
cannulas (30 Gauge). The infusion cannula was connected by
polyethylene tubing (PE 10; Becton Dickinson, Sparks, MD,
USA) with a stepper-motorized micro-syringe (Stoelting, Wood
Dale, IL, USA). SKF38393 (4.8 nmol), SCH23390 (0.6 nmol)
and H89 (0.8 nmol) were diluted with ACSF and infused daily
in a volume of 0.2 µl/side (Lai et al., 2008; Nasehi et al.,
2011). After 2% Evans-blue (2.5 µl) was injected, the mice
were killed by an overdose of chloral hydrate, and coronal
sections (100 µm) were cut using a cryostat to validate the
injection-site. Control mice were given an equal volume of
vehicle.
Behavioral Examination
A single cohort of animals was used for the following test
sequence: open-field test (OFT) → Forced swim test (FST) →
Tail suspension test (TST; Zhou et al., 2014). All behavioral data
were captured by a video-monitor and analyzed using TopScan
Lite 2.0 (Clever Sys., Reston, VA, USA).
OFT was performed in a cuboid Plexiglass box (60 cm × 60
cm× 40 cm). Total distance traveled (mm/6 min) was recorded.
FST was performed in a glass cylinder (300 mm high, 280
mm in diameter) that was filled with water (25 ± 1◦C) to a
height of 20 cm. Total immobility time during a 6 min test was
scored. Mice were considered to be immobile when they stopped
struggling and moved only to remain floating in the water, while
keeping their heads above water.
TST was performed by using adhesive tape to attach the tail to
a rod that was 60 cm above the floor. Trials were conducted for a
period of 6 min, during which the immobility time was recorded.
Morris water maze task (MWM) was performed in a black-
colored plastic pool (diameter = 120 cm) at 20 ± 1◦C. A
cylindrical platform (diameter = 7 cm) was placed 0.5 cm below
the surface of water. Each mouse was randomly released from
four different quadrants and allowed to swim for 90 s. Four trials
were conducted each day with an intertrial interval of 30 min.
Average swimming speed (m/s) and latency (s) to reach the
platform were scored for all trials. If a mouse could not reach the
platform within 90 s, the experimenter gently assisted the mouse
onto the platform and allowed it to remain there for 15 s.
Immuno-Staining and Quantification
BrdU Immuno-Staining
Mice were anesthetized with chloral hydrate (400 mg/kg, i.p.)
and perfused transcardially with 4% paraformaldehyde on day 1
(D1), day 7 (D7) , day 14 (D14) and day 21 (D21) after the last-
injection of BrdU. Coronal hippocampal slices (40 µm) were cut
using a vibrating microtome (Microslicer DTK 1500; Dousaka
EM Co, Japan). The d-DG (AP: −0.94 to −2.30) and the v-DG
(AP:−2.46 to AP:−3.80) were each harvested on the basis of the
coordinates of the Paxinos and Franklin atlas of the mouse brain
(O’Leary et al., 2012). The free-floating sections were treated
with 3% normal goat serum, and then incubated with mouse
anti-BrdU antibody (1:1000, Millipore, Billerica, MA, USA) at
4◦C overnight. The sections were incubated in biotin-labeled
goat anti-mouse IgG antibody (1:500, Bioworld Technology,
Inc., St. Louis Park, MN, USA) for 2 h. Immunoreactivities
were visualized using an avidin-biotin horseradish peroxidase
complex (Vector Laboratories, Inc., Burlingame, CA, USA).
BrdU-positive (BrdU+) cells in SGZ and granule cell layer
of every 5th section (200 µm apart) were counted using a
conventional light microscope (DP70, Olympus Optical, Tokyo,
Japan). The number of BrdU+ cells per section was multiplied by
five to obtain the total number per DG (Sha et al., 2015).
BrdU and NeuN or GFAP Double Immuno-Staining
The sections were incubated with rat anti-BrdU antibody (1:200,
Abcam, Cambridge, UK), which was detected using CY3-
labeled anti-rat IgG antibody (1:200, Millipore) and mouse anti-
neuronal nuclei (NeuN) antibody (1:500, Millipore), which was
detected using fluorescein-labeled anti-mouse antibody (1:50,
Millipore) or mouse anti-GFAP antibody (1:200, Millipore),
which was detected using a FITC-labeled anti-mouse antibody
(1:50, Millipore). BrdU+/NeuN+ or GFAP+ cells were observed
using a confocal laser-scanning microscope (Leica, Heidelberg,
Germany). The number of BrdU+/NeuN+ or GFAP+ cells per
section (200 µm apart) was multiplied by 5 to obtain the total
number.
Doublecortin (DCX) or Tyrosine Hydroxylase (TH)
Immuno-Staining
The free-floating sections (40 µm) were incubated with goat
anti-DCX antibody (1:500, Santa Cruz, CA, USA) or chicken
anti-TH (1:1000, Abcam) at 4◦C overnight, and then in biotin-
labeled rabbit anti-goat IgG antibody (1:500, Bioworld) or
goat anti-chicken IgG antibody (1:500, Santa Cruz) for 2 h at
room temperature. Density of doublecortin positive (DCX+)
cells was expressed as the number per mm length along SGZ
(Sha et al., 2015). Tyrosine hydroxylase positive (TH+) cells
were counted using a stereological system, which consisted of
a light microscope with a CCD camera (DP70), a motorized
specimen stage for automatic sampling and a computer running
Microbrightfield Stereo Investigator software (Microbrightfield,
Williston, VT, USA; Hong et al., 2015).
Western Blot Analysis
After the dorsal and ventral hippocampal slices were harvested,
the DG regions were micro-dissected and stored at −80◦C
until assayed. Protein was extracted and the concentration
of protein was determined using a bicinchoninic acid (BCA)
protein assay kit (Pierce, IL, USA). Protein (40 µg) was
separated by 10% acrylamide denaturing gels (SDS-PAGE) and
transferred to membranes. The membranes were incubated
with rabbit anti-protein kinase A (PKA) phosphorylation
(1:1000, Millipore) and rabbit anti-cyclic AMP-response
element binding protein (CREB) phosphorylation (1:1000,
Santa Cruz, CA, USA). Then, the membranes were incubated
with horseradish peroxidase-labeled goat anti-rabbit antibody
(1:5000, Santa Cruz, CA, USA), and developed using an
enhanced chemiluminescence detection kit (Millipore). After
visualization, the blots were stripped by incubation in stripping
buffer for 15 min, and then incubated with rabbit anti-PKA
antibody (1:1000, Millipore) and rabbit anti-CREB antibody
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(1:1000, Santa Cruz, CA, USA). An internal control was
performed using mouse anti-β-actin antibody (1:2000, Cell
Signaling, Danvers, MA, USA). Western blot bands were
scanned and analyzed with the ImageJ analysis software package
(NIH).
Reverse Transcription-Polymerase Chain
Reaction (RT-PCR)
Total RNA of v-DG and d-DG was isolated using TRIzol reagent
(Invitrogen, Camarillo, CA, USA) and reverse-transcribed into
cDNA using a PrimeScript RT reagent kit (Takara, China) for
quantitative PCR (ABI Step One Plus, Foster City, CA, USA) in
the presence of a fluorescent dye (SYBR Green I; Takara). The
relative expression of genes was determined using the 2−11ct
method with normalization to the GAPDH expression. The
primer sequences of D1R and D2R mRNA were designed as
described in a previous publication (Kim et al., 2010).
Statistical Analysis
The group data were expressed as the means ± standard
error (SEM). All statistical analyses were performed using SPSS
software, version 16.0 (SPSS Inc., Chicago, IL, USA). Differences
among means were analyzed using the Student’s t-tests or
one/two-factor analysis of variance (ANOVA) or repeated-
measures ANOVA, followed by a post hoc Bonferroni test.
Differences of p< 0.05 were considered statistically significant.
RESULTS
MPTP Causes Depression-Like Behaviors
in Mice
MPTP injection had a marked effect on the dopaminergic
neurons in VTA (F(4,49) = 6.767, p < 0.001; Figure 1A). In
comparison with the control values, the number of TH+ cells on
day 1 (D1, p< 0.05), day 7 (D7, p< 0.01), day 14 (D14, p< 0.01)
and day 21 (D21, p< 0.01) after the last-injection ofMPTP (post-
MPTP) was significantly reduced.
The affective behaviors were examined on days 5–7, days
12–14 and days 19–21 post-MPTP (Figure 1B). MPTP-mice
had a tendency to travel a shorter total distance in the OFT
(Figure 1C), but the group comparison with control mice
failed to reach statistical difference (F(1,54) = 0.825, p = 0.368).
Depression-like behaviors were examined by FST and TST.
There was a main effect of MPTP-injection for the immobility
time in FST (F(1,54) = 16.130, p < 0.001; Figure 1D) and
TST (F(1,54) = 15.360, p < 0.001; Figure 1E). Notably, MPTP-
mice showed a progressive prolongation of immobility time
in FST and TST from day 13–14 (FST: p < 0.05; TST:
p < 0.05) to day 20–21 (FST: p < 0.01; TST: p < 0.01) post-
MPTP.
The spatial memory was further examined using the place
learning of the MWM on days 22–26 post-MPTP. Repeated-
measures ANOVA revealed that the escape latency of hidden
platform progressively decreased with training days in all groups
(F(4,72) = 59.308, p < 0.001; Figure 1F), which was not affected
by the MPTP-injection (F(1,18) = 0.049, p= 0.828).
MPTP Impairs the Survival of Newborn
Neurons in Ventral DG
To investigate the mechanisms underlying the MPTP-induced
depression-like behaviors, we examined the dopaminergic
innervations and the hippocampal neurogenesis in d-DG and
v-DG (Figure 2A). In control mice, the density of TH
positive (TH+) fibers in v-DG was higher than that in d-DG
(Figure 2B). In comparison with those of controls, the TH+
fibers in v-DG were clearly decreased on day 7 post-MPTP.
The BrdU was injected starting from 4 h post-MPTP. BrdU+
cells were examined on day 1 (D1), day 7 (D7), day 14
(D14) and day 21 (D21) after the BrdU-injection (Figure 2C).
The number of BrdU+ cells (D1→D7→D14→D21) in either
d-DG (F(3,72) = 57.836, p < 0.001; Figure 2D) or v-DG
(F(3,72) = 64.856, p < 0.001; Figure 2E) were decreased
progressively in all groups. MPTP injection markedly reduced
the number of BrdU+ cells in v-DG (F(1,72) = 7.800,
p = 0.007), but not in d-DG (F(1,72) = 3.497, p = 0.066).
In comparison with controls, the MPTP-mice had significantly
fewer D7-BrdU+ cells (p < 0.01), D14-BrdU+ cells (p < 0.01)
and D21-BrdU+ cells (p < 0.01), but not D1-BrdU+ cells
(p > 0.05), in v-DG. However, the numbers of D1-BrdU+
cells (p > 0.05), D7-BrdU+ cells (p > 0.05), D14-BrdU+
cells (p > 0.05) and D21-BrdU+ cells (p > 0.05) in d-DG
had no significant difference between MPTP-mice and control
mice.
Doublecortin (DCX), a microtubule-associated protein, is
specifically expressed in immature neuroblasts and progenitor
cells (Francis et al., 1999). To evaluate the survival of young
newborn neurons, we examined the number of DCX+ cells in
the hippocampal DG on day 7 post-MPTP. The results showed
that the number of DCX+ cells was significantly reduced in v-DG
(p< 0.01, n= 10; Figure 2F), but not in d-DG (p> 0.05, n= 10),
compared with those in control mice.
To examine the differentiation of precursor cells, we further
examined the number and relative proportions of D21-BrdU+
cells expressing NeuN, a mature neuronmarker, or glial fibrillary
acidic protein (GFAP), a glial marker. The number of D21-
BrdU+/NeuN+ cells in v-DG of MPTP-mice was less than
that in control mice (p < 0.01, n = 10; Figure 2G), whereas
there was no difference in d-DG between the both (p > 0.05,
n = 10). In contrast, the number of D21-BrdU+/GFAP+ cells
in v-DG (p > 0.05, n = 10; Figure 2H) or d-DG (p > 0.05,
n = 10) did not differ between MPTP-mice and control mice.
In v-DG of MPTP-mice, the ratio of BrdU+/NeuN+ cells to
total D21-BrdU+ cells (53.79 ± 5.02%) was lower than that
in control mice (76.60 ± 5.48%, p < 0.01, n = 10), whereas
the ratio of BrdU+/GFAP+ cells (15.06 ± 1.09%) was higher
than the ratio in control mice (10.54 ± 0.74%, p < 0.01,
n= 10).
MPTP Reduces D1R-Activated PKA-CREB
Signaling
The RT-PCR analysis showed that the levels of D1R (v-DG:
p > 0.05; d-DG: p > 0.05, n = 8; Figure 3A) and D2R mRNA
(v-DG: p > 0.05; d-DG: p > 0.05, n = 8; Figure 3B) were
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FIGURE 1 | Influence of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopamine (DA) depletion on affective behaviors in mice.
(A) Representative photomicrographs of tyrosine hydroxylase (TH) immuno-staining in ventral tegmental area (VTA; a circular area is indicated by white line). Scale
bars = 40 µm. Stereological counts of TH+ cells throughout VTA on day 1 (D1), 7 (D7), 14 (D14) and 21 (D21) after the last-injection of MPTP (post-MPTP).
∗p < 0.05 and ∗∗p < 0.01 vs. control mice (one-way ANOVA). (B) Time chart of the experimental procedure. Horizontal open arrow indicates the time post-MPTP
(day). Vertical open arrows indicate the time of open-field test (OFT), forced swim test (FST) and tail suspension test (TST) and Morris water maze task (MWM).
(C) Each point represents the total distance traveled within 6 min in OFT on day 5, 12 and 19 post-MPTP, respectively. (D,E) The points indicate the immobility time
in FST and TST on days 6–7, days 13–14 and days 20–21 post-MPTP, respectively. ∗p < 0.05 and ∗∗p < 0.01 vs. control mice (two-way ANOVA). (F) Each point
represents the mean latencies (sec) to reach the hidden platforms on days 22–26 post-MPTP.
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FIGURE 2 | Influence of MPTP-induced DA depletion on neurogenesis in dentate gyrus (DG). (A) Schematic diagram of dorsal DG (d-DG) and ventral DG
(v-DG; orange area). (B) Representative pictures of TH+ fibers (white arrows) in d-DG and v-DG on day 7 post-MPTP. Scale bars = 50 µm. (C) Time chart of the
experimental procedure. Horizontal open arrow indicates the time after BrdU-injection (day). Vertical open arrows indicate the time of BrdU immuno-staining.
(D,E) Representative images of BrdU-positive (BrdU+) cells (black arrows) in d-DG (D) and v-DG (E). Scale bar = 100 µm. The points represent the mean number of
D1-, D7-, D14- and D21-BrdU+ cells in d-DG and v-DG. ∗∗p < 0.01 vs. control mice (two-way ANOVA). (F) Bar graph shows the mean number of DCX-positive
(DCX+) cells in d-DG and v-DG on day 7 post-MPTP. ∗∗p < 0.01 vs. control mice (Student’s t-tests). Representative images of DCX+ cells (white arrows). ML:
molecular layer; GL: granular cell layer. Scale bar = 50 µm. (G,H) Bar graph shows the mean number of D21-BrdU+/NeuN+ cells and D21-BrdU+/GFAP+ cells in
d-DG and v-DG. ∗∗p < 0.01 vs. control mice. Representative images of BrdU+/NeuN+ cells (G) and BrdU+/GFAP+ (H) cells (white arrows). Neuronal nuclei (NeuN)
and glial fibrillary acidic protein (GFAP) are shown in green and BrdU is shown in red, newborn cells are shown in yellow. Scale bars = 50 µm.
not altered on day 7 post-MPTP. Compared with the control
levels, the phosphorylation of PKA (p-PKA: p< 0.01; Figure 3C)
or CREB (p-CREB: p < 0.01, n = 8; Figure 3D) in v-DG
was reduced on day 7 post-MPTP, which was reversed by the
administration of D1R agonist SKF38393 for 2 days (p < 0.01,
n = 8). The PKA inhibitor H89 could block the D1R-reversed
CREB phosphorylation in v-DG ofMPTP-mice (p< 0.05, n= 8).
The administration of D1R antagonist SCH23390 for 2 days to
control mice decreased the phosphorylation of PKA (p < 0.01)
and CREB (p < 0.01, n = 8) in v-DG. Consistently with the
results of a report by Zhao et al. (2013), the activation of D2R
by quinpirole led to a decline in the phosphorylation of PKA
(p < 0.05) and CREB (p < 0.05, n = 8) in v-DG of control mice,
whereas the D2R antagonist L-sulpiride had no effects (p> 0.05,
n = 8). The treatment of MPTP-mice with quinpirole showed a
tendency to decrease the phosphorylation of PKA and CREB in
v-DG, but the difference had no statistical significance (p> 0.05,
n = 8). In contrast, MPTP-mice did not show the changes in the
levels of the PKA and CREB phosphorylation (p > 0.05, n = 8)
in d-DG compared with those of controls, which was not affected
by SKF38393 (p > 0.05, n = 8) or quinpirole (p > 0.05, n = 8).
Furthermore, the phosphorylation of PKA or CREB in d-DG of
control mice was not altered by the application of SCH23390
(p> 0.05, n= 8) or L-sulpiride (p> 0.05, n= 8).
MPTP Reduces the D1R-Mediated Survival
of Newborn Neurons
The newborn cells in the adult hippocampal DG express
functional D1R and D2R (Takamura et al., 2014). To test
whether the down-regulation of D1R-activated PKA-CREB
signaling affects the survival of young newborn neurons, MPTP-
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FIGURE 3 | Influence of MPTP-induced DA depletion on phosphorylation of PKA and CREB. (A,B) Levels of D1-like receptors (D1R) and D2R mRNA in
d-DG and v-DG on day 7 post-MPTP. (C,D) Bar graphs show the mean levels of PKA and CREB phosphorylation in d-DG and v-DG of MPTP-mice untreated or
treated with SKF38393 (SKF, 10 mg/kg, i.p.), H89 (1 mg/kg, i.p.) or quinpirole (Quin, 2 mg/kg, i.p.) for 2 days and control mice untreated or treated with SCH23390
(SCH, 0.5 mg/kg, i.p.) or L-sulpiride (L-s, 15 mg/kg. i.p.) for 2 days. ∗p < 0.05 and ∗∗p < 0.01 vs. control mice; ##p < 0.01 vs. MPTP-mice; +p < 0.05 vs.
MPTP-mice treated with SKF.
mice were treated with SKF38393 or quinpirole daily on days
2–7 after the BrdU-injection, and control mice received the
treatment with SCH23390, L-sulpiride or quinpirole. Then,
we examined the number of D7- and D21-BrdU+ cells,
respectively (Figure 4A). As shown in Figures 4B,C, the
treatment with SKF38393 in MPTP-mice not only rescued
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the loss of D7-BrdU+ cells (p < 0.01, n = 10), but also
corrected the reduction of D21-BrdU+ cells (p < 0.01, n = 10)
in v-DG, which was sensitive to H89 (p < 0.05, n = 10).
However, the administration of quinpirole to MPTP-mice
had no effects on the reduced D7- or D21-BrdU+ cells in
v-DG (p > 0.05, n = 10). Interestingly, the treatment of
control mice with either SCH23390 (p < 0.01, n = 10) or
quinpirole (p < 0.05, n = 10), but not L-sulpiride (p > 0.05,
n = 10), caused a decrease in the number of D7-BrdU+
cells in v-DG, which was associated with the reduction of
D21-BrdU+ cells (SCH23390: p < 0.01, n = 10; quinpirole:
p < 0.05, n = 10). In contrast, the number of D7- or D21-
BrdU+ cells in d-DG of control mice was not affected by
SCH23390, quinpirole or L-sulpiride (p > 0.05, n = 10).
However, the application of SKF38393 on days 16–21 after the
BrdU-injection had no effect on the reduced D21-BrdU+ cells
in v-DG of MPTP-mice (p > 0.05, n = 10; Figure 4D). At
the same time, the treatment of control mice with SCH23390
did not change the number of D21-BrdU+ cells in v-DG
(p > 0.05, n = 10). Additionally, the administration of
SKF38393 for 6 days post-MPTP could increase the number
of DCX+ cells in v-DG (p < 0.01, n = 10; Figure 4E), while
the activation of D2R by quinpirole could not (p > 0.05,
n = 10). Similarly, the treatment of control mice with
SCH23390 (p < 0.01, n = 10), but not L-sulpiride (p > 0.05,
n = 10), caused a reduction in the number of DCX+ cells in
v-DG.
Association of MPTP-Impaired
Neurogenesis With Depressive-Like
Behaviors
To explore whether the impaired neurogenesis in MPTP-mice
is related to their depressive-like behaviors, MPTP-mice were
treated with SKF38393 or quinpirole for 18 days starting from
the first-injection ofMPTP, and control mice received SCH23390
and quinpirole for 18 days (Figure 5A). To avoid the direct
effects of drugs, the affective behavioral tests were performed on
days 6–7 after the end of the drugs administration. The results
showed that the treatment of MPTP-mice with SKF38393, but
not quinpirole, corrected the prolongation of the immobility
time in FST (p < 0.05, n = 10; Figure 5B) and TST (p < 0.01,
n = 10; Figure 5C), which was blocked by H89 (FST: p < 0.05;
TST: p < 0.05, n = 10). In addition, the administration
of SCH23390 (FST: p < 0.01; TST: p < 0.01, n = 10) or
quinpirole (FST: p < 0.05; TST: p < 0.05, n = 10) to control
mice caused an increase in the immobility time of FST and
TST.
To determine further the relationship between the MPTP-
impaired neurogenesis and the depressive-like behaviors, MPTP-
mice were treated with the v-DG injection of SKF38393
(Figure 5E), and control mice received the v-DG injection
of SCH23390 and H89 for 18 days (Figure 5D). Similarly,
the v-DG injection of SKF38393 in MPTP-mice could prevent
the prolongation of the immobility time in FST (p < 0.05,
n = 10; Figure 5F) and TST (p < 0.01, n = 10; Figure 5G)
and the reduction of D21-BrdU+ cells in v-DG (p < 0.01,
n = 10; Figure 5H). The v-DG injection of SCH23390
and H89 in control mice caused the prolongation of the
immobility time in FST (SCH23390: p < 0.01, n = 10; H89:
p < 0.05, n = 10) and TST (SCH23390: p < 0.05, n = 10;
H89: p < 0.05, n = 10) and the loss of D21-BrdU+ cells
in v-DG (SCH23390: p < 0.01, n = 10; H89: p < 0.05,
n= 10).
DISCUSSION
The present study provides evidence that the MPTP-induced
decline of dopaminergic afferents in v-DG impairs the D1R-
mediated early survival of newly generated neurons, and
this deficit in hippocampal neurogenesis is associated with
depressive-like behaviors.
The adult DG contains at least two types of proliferating
immature cells: GFAP+ radial glia-like cell (B-cell) and GFAP−
cell (C-cells). The B-cells, as stem cells, generate frequently
dividing transit-amplifying C-cells. Asymmetrically divided
C-cells are more likely to be progenitor cells and can differentiate
into neural precursors or DCX+ neuroblasts (A-cells; Zhao
et al., 2008). D2R is predominantly expressed in C-cells,
while A-cells express both D1R and D2R (Höglinger et al.,
2004). The activation of D2R has been reported to stimulate
C-cell proliferation (Yang et al., 2008). The number of D1-
BrdU+ cells in v-DG or d-DG of MPTP-mice was not altered,
although the dopaminergic neurons in VTA were reduced by
approximately 25% on day 1 post-MPTP. The microtubule-
associated protein DCX expression is specific to newly generated
neurons, but not to glial cells and undifferentiated cells,
which reaches a peak during the second week and is down-
regulated concomitantly with the appearance of NeuN (Rao
and Shetty, 2004). DCX, as an immature neuron marker,
is used to evaluate the survival of young newborn neurons
(Kim et al., 2009). MPTP-mice had a significant decrease
in the DCX+ cells in v-DG, which could be rescued by
the activation of D1R rather than D2R. In addition, the
blockade of D1R caused a decrease of the DCX+ cells in
v-DG of control mice. The number of D7-BrdU+ cells in
v-DG of MPTP-mice was reduced. Although fewer D14- or
D21-BrdU+ cells were found in v-DG of MPTP-mice than
those in control mice, the percentage of reduced BrdU+
cells (D7 → −25% D14 → −57% D21) in MPTP-mice did
not differ from control mice (D7 → −20% D14; D14→
−52% D21). Therefore, it is likely that the MPTP-induced
DA depletion mainly impairs the early survival of newborn
neurons in v-DG. Khaindrava et al. (2011) have reported
that DA depletion causes deficits in the survival of newborn
cells in DG. Our pharmacological experiments support this
idea by showing that in MPTP-mice, the D1R agonist when
administered on days 2–7 after BrdU-injection rescued the
loss of D7- or D21-BrdU+ cells, but when administered on
days 16–21 after BrdU-injection, it failed to alter the reduced
D21-BrdU+ cells in MPTP-mice. Moreover, the blockade of
D1R on days 2–7 after BrdU-injection reduced the number
of D7- and D21-BrdU+ cells in control mice. The absolute
number of D21-BrdU+/NeuN+ cells and proportion of these
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FIGURE 4 | Involvement of D1R and D2R in MPTP-impaired survival of newborn neurons. (A) Time chart of the experimental procedure. The drugs were
administered on days 2–7 after the BrdU-injection (black part). (B,C) Bar graph shows the mean number of D7-BrdU+ cells and D21-BrdU+ cells in d-DG and v-DG
of MPTP-mice treated with SKF38393 (SKF), H89 or quinpirole (Quin) or control mice treated with SCH23390 (SCH), L-sulpiride (L-s) or Quin. ∗p < 0.05 and
∗∗p < 0.01 vs. control mice; ##p < 0.01 vs. MPTP-mice; +p < 0.05 vs. MPTP-mice treated with SKF. (D) Bar graph shows the mean number of D21-BrdU+ cells in
v-DG when the drugs were administered on days 16–21 after the BrdU-injection. ∗∗p < 0.01 vs. control mice. (E) Bar graph shows the mean number of DCX+ cells
in v-DG when the drugs were administered on days 2–7 post-MPTP. ∗∗p < 0.01 vs. control mice; ##p < 0.01 vs. MPTP-mice.
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FIGURE 5 | Influence of MPTP-induced DA depletion on depressive-like behaviors. (A) Time chart of SKF38393 (SKF), quinpirole (Quin), SCH23390 (SCH)
and H89 injection (i.p.) for 18 days (black part). (B,C) Bar graphs show the immobility time in FST and TST on days 6–7 after the last-administration of drugs.
∗p < 0.05 and ∗∗p < 0.01 vs. control mice. #p < 0.05 and ##p < 0.01 vs. MPTP-mice.+p < 0.05 vs. MPTP-mice treated with SKF. (D) Time chart of v-DG injection
of SKF38393 (SKF), SCH23390 (SCH) and H89 for 18 days (black part). (E) The representative Evans-blue image of v-DG injection (right panel) and schematic
diagram of v-DG (left panel). Scale bar = 1.0 mm. Black arrow indicates the site of the v-DG injection (black spot). CA3: hippocampal CA3 region. (F,G) Bar graphs
show the immobility time in FST and TST on days 6–7 after the v-DG last-injection of drugs. ∗p < 0.05 and ∗∗p < 0.01 vs. control mice. #p < 0.05 and ##p < 0.01
vs. MPTP-mice. (H) Bar graph shows the mean number of D21-BrdU+ cells in v-DG. ∗p < 0.05 and ∗∗p < 0.01 vs. control mice. ##p < 0.01 vs. MPTP-mice.
cells relative to the total D21-BrdU+ cells were reduced in
v-DG of MPTP-mice. The number of BrdU+/GFAP+ cells in
v-DG of MPTP-mice did not differ from control mice, and
the ratio of BrdU+/GFAP+ cells was higher than the ratio in
control mice. Thus, it is conceivable that the MPTP-induced
DA depletion does not affect the differentiation of precursor
cells. On the other hand, the number of BrdU+ cells, DCX+
cells, BrdU+/NeuN+ cells or BrdU+/GFAP+ cells in d-DG
did not differ between control and MPTP-mice, which was
not affected by the activation or blockade of D1R and D2R.
Consistently with the report by Bjarkam et al. (2003), there
was few dopaminergic projections in d-DG, indicating that
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the neurogenesis process in d-DG may be insensitive to the
dopaminergic regulation.
The administration of D1R agonist to MPTP-mice could
rescue the loss of D7-BrdU+ cells in a PKA-dependent manner,
but the D2R agonist did not. The major signaling cascaded by
D1R activation is the cAMP-PKA pathway in the hippocampus
(Arnsten and Dudley, 2005). PKA-CREB signaling is one of the
most important pathways for promoting neuron regeneration
in DG (Miyamoto et al., 2009). The activation of PKA induces
the phosphorylation of CREB at Ser-133, thereby facilitating the
gene transcription of key molecules such as c-Fos, Jun-B, Bcl-
2, GDNF and neurotrophins to regulate neuronal survival and
regeneration. Inhibition of phosphodiesterase-4, an enzyme that
catalyzes the hydrolysis of cAMP, stimulates the activation of
CREB and increases the survival of newborn cells (Nakagawa
et al., 2002). In this study, we observed the decline of PKA and
CREB phosphorylation in v-DG of MPTP-mice without changes
in the expression of D1R. In v-DG of MPTP-mice, the decrease
of PKA and CREB phosphorylation could be corrected by the
D1R agonist and the protection of D1R agonist on the D7-BrdU+
cells was blocked by the inhibition of PKA. The blockade of D1R
caused the loss of D7-BrdU+ cells and decline of PKA and CREB
phosphorylation in v-DG of control mice. The D2R antagonist
haloperidol has been shown to decrease (Wakade et al., 2002),
increase (Kippin et al., 2005) or not affect (Malberg et al.,
2000) hippocampal neurogenesis. Our results showed that the
activation of D2R reduced the PKA and CREB phosphorylation
and the D7-BrdU+ cells in v-DG of control mice. Therefore, it
is proposed that the MPTP-induced DA depletion through the
down-regulation of D1R-induced PKA-CREB signaling impairs
the early survival of newborn neurons in v-DG.
It is widely accepted that the hippocampal neurogenesis is
required for mood control (Petrik et al., 2012) and cognitive
performance (Rola et al., 2004). Selectively impairing the adult
neurogenesis by telomerase inhibitor could cause the depression-
like behaviors in mice (Zhou et al., 2011a). Irradiation of young
animals impairs hippocampal neurogenesis that is associated
with cognitive deficits (Rola et al., 2004). The newly generated
neurons are integrated into the neuronal circuitry within 3–4
weeks after birth (Zhao et al., 2006) to regulate hippocampal
output (Ming and Song, 2011). Importantly, we have observed
the depressive-like behaviors in MPTP-mice for 2–3 weeks later
after DA depletion. The timing of depressive-like behaviors
in MPTP-mice seems to be coincident with the loss of
mature newborn neurons. Interestingly, MPTP-mice did not
appear affected by the spatial cognitive deficits, although they
showed depressive-like behaviors. One possible explanation may
be a difference in the regions of impaired neurogenesis in
hippocampal DG. The idea may be supported by the facts that
the lesions in the dorsal hippocampus affect spatial learning
and memory (Moser et al., 1995), while lesions of the ventral
hippocampus lead to anxiety and depressive-like behaviors
(McHugh et al., 2004). The antidepressants may exert their
behavioral effects by increasing neurogenesis in v-DG (Banasr
et al., 2006). In particular, the v-DG injection of SKF38393
in MPTP-mice not only reduced the loss of D21-BrdU+ cells
but also relieved the depressive-like behaviors. In control mice,
the v-DG injection of either SCH23390 or H89 caused the
reduction of D21-BrdU+ cells in v-DG, which was companied
by the production of depressive-like behaviors. These results
indicate a possible cause-and-effect relationship between the
MPTP-impaired neurogenesis and the MPTP-induced affective
disorder. In addition, the ventral hippocampus is involved in
regulation of the hypothalamic-pituitary-adrenal axis (Herman
et al., 1995), buffering the stress response (Snyder et al., 2011).
The basolateral amygdaloid complex receives the hippocampal
afferents (Supcun et al., 2012). Hippocampal dysfunction affects
the synaptic plasticity of the basolateral amygdaloid complex,
which is important for the acquisition and consolidation of fear
memories (Goosens and Maren, 2002) and the extinction of
learned fear (Dalton et al., 2012).
Forebrain DA circuitry has been studied by two largely
independent researchers: a nigrostriatal DA system that
originates in the substantia nigra (SN) and a mesolimbic DA
system that originate in the VTA. MPTP selectively destroys the
dopaminergic neurons in the SN and VTA (Lu et al., 2014; Hong
et al., 2015; the present study). Target neurons in the primary
terminal field of the SN are striatal medium spiny neurons. It
is well known that the MPTP-induced loss of dopaminergic
neurons in SN pars compacta through the striatal DA depletion
impairs the motor functions including slowness, rigidity, resting
tremor and postural instability (Fahn, 2003). The projection
fields of VTA DA neurons are the hippocampus or medial
prefrontal cortex, which contributes to the emotional regulation
(Russo and Nestler, 2013). Tye et al. (2013) have reported that
the selective inhibition of VTA DA neurons acutely induces
multiple distinct depression-like behaviors. Furthermore, the
dopaminergic fibers from VTA dopaminergic neurons have
been reported to contact directly with the newborn cells in
DG (Höglinger et al., 2004). Taken together, the results in the
present study give an indication that the MPTP-impaired VTA
dopaminergic neurons leading to the dopaminergic deficiency
in v-DG, impairs the D1R-mediated early survival of newborn
neurons.
The present study provides evidence that the MPTP-induced
dopaminergic depletion impairs the D1R-mediated early survival
of newly generated neurons in v-DG; this impairment of
hippocampal neurogenesis is associated with the production
of the depressive-like behaviors. Thus, D1R agonists may be
candidate substrates for treating PD depression.
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